NCT02945241View on ClinicalTrials.gov

Cystatin-C C-guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project

PHASE1CompletedINTERVENTIONAL
Enrollment

399

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

March 31, 2016

Conditions
Methicillin-resistant Staphylococcus AureusSepsisCritical Illness
Interventions
DRUG

Vancomycin

Intravenous

OTHER

Cystatin C dosing algorithm

Expressed in milliliters per minute

OTHER

Creatine clearance dosing algorithm

Vancomycin dosing algorithm based on creatinine clearance, expressed in milliliters per minute

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER